Investigation of vitamin D levels in patients with inactive hepatitis B virus carrier

Basit Öğe Kaydı
dc.authorscopusid34875451400
dc.authorscopusid55185166900
dc.authorscopusid55567414500
dc.authorscopusid16231562400
dc.authorscopusid6603160510
dc.authorscopusid22952593700
dc.authorscopusid8927152600
dc.contributor.authorMotor, Sedat
dc.contributor.authorKoksaldi-Motor, Vicdan
dc.contributor.authorDokuyucu, Recep
dc.contributor.authorUstun, Ihsan
dc.contributor.authorEvirgen, Omer
dc.contributor.authorYilmaz, Nigar
dc.contributor.authorOnlen, Yusuf
dc.date.accessioned2024-09-19T15:48:33Z
dc.date.available2024-09-19T15:48:33Z
dc.date.issued2014
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractObjective: The purpose of the present study was to investigate vitamin D levels in inactive hepatitis B virus carriers. Materials and methods: A total of 81 patients with inactive hepatitis B virus carrier state were enrolled at the study. Serum calcium (Ca++), phosphorus (PO4), total protein, albumin, parathormone (PTH) and 25-hydroxy vitamin D (25OHD) were determined. Serum vitamin D concentration was classified as lacking when it was less than 50 nmol/l (20 ng/ml), insufficient when it was 52.5-72.5 nmol/l (21-29 ng/ml), and sufficient when it was more than 75 nmol/l (30-100 ng/ml). Results: The mean 25OHD level was found to be 131.7±50.0 nmol/l. Deficiency and insufficiency was seen in one (1.2 %) and nine (11.1 %) inactive hepatitis B virus carriers, respectively. All the patients have normal serum PTH and albumin levels. Total Ca++ and PO4 were low in ten and eight patients, respectively (p<0.05). Conclusion: Vitamin D may cause the stimulation of antiviral immune response and a preventive effect on necroinflammation and liver fibrosis. Therefore, it may affect course of HBV infection. The new studies with larger sample are needed to research the role of vitamin D in the course of chronic HBV infection, liver failure, cirrhosis, and hepatocellular carcinoma.en_US
dc.identifier.endpage796en_US
dc.identifier.issn0393-6384
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84903468671en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage793en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/15153
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherActa Medica Mediterraneaen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis B virus infectionen_US
dc.subjectImmunityen_US
dc.subjectInactive carrieren_US
dc.subjectVitamin Den_US
dc.titleInvestigation of vitamin D levels in patients with inactive hepatitis B virus carrieren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu